Specialist in Preventive Medicine and Public Health, Deputy Director General of Public Health of the Region of Murcia and President of the Spanish Association of Vaccinology
An Australian team has conducted a study involving mice and humans that suggests that vaccine boosters would be more effective if administered in the same arm as the previous dose, at least in the short term. However, other recent research has pointed in the opposite direction. The results are published in the journal Cell.
In a clinical trial of nearly 5,000 children aged 5-36 months, a new malaria vaccine - called R21/MatrixM - reduced symptomatic cases by 68-75% over the following year. According to the authors, the vaccine will be inexpensive and could contribute to a substantial reduction in malaria suffering and deaths in sub-Saharan Africa. The results of the phase 3 trial are published in The Lancet.